Medicare's payment overhaul for skin substitute grafts took effect January 1, 2026, cutting reimbursement to a flat $127.14 per square centimeter under the CY2026 Medicare Physician Fee Schedule and folding most products into a single incident-to payment category. Medicare Administrative Contractors have not relaxed the underlying medical-necessity standard to match the lower rate, and the billing code has drawn heavier post-payment review as a result. A wound care provider who wants a skin substitute claim to survive audit needs a chart that documents the specific product chosen, the conservative care that preceded it, and the wound's measured progress. Claims collapse on audit far more often because the record never captured that judgment than because the judgment itself was unsound.
Documenting Conservative Care Before a Skin Substitute
Medicare Administrative Contractors require a documented trial of conservative wound care before a skin substitute graft qualifies as medically necessary. The standard window is at least four weeks of standard treatment, including debridement, offloading, compression, infection control, and a vascular assessment, with the wound record showing the treatment did not produce the expected reduction in wound area. A chart that moves straight to a skin substitute without that documented trial invites a denial regardless of the clinical outcome. The conservative care period has to be traceable: dated encounter notes, the specific interventions used, and wound measurements taken during the window, not a single summary sentence written after the fact. Local Coverage Determinations governing skin substitute grafts for diabetic foot ulcers and venous leg ulcers describe this trial period as a condition of coverage, and auditors treat it the same way.
A skin substitute claim survives audit on what the chart proves happened, not on what the clinician remembers doing.
Selecting and Justifying the Product
CMS groups skin substitute products into three FDA-based categories for CY2026 payment purposes: products regulated under section 361 of the Public Health Service Act, 510(k)-cleared devices, and PMA-approved devices, alongside a smaller set of products still paid under the prior ASP-plus-6% methodology. The reimbursement rate no longer varies much by product, but the legal requirement to justify the specific product chosen has not changed. The note has to explain why this product, for this wound, on this patient: the wound's size and depth, the patient's vascular status and comorbidities such as diabetes, and why the chosen product fits the wound's characteristics better than an alternative on the payer's covered list. Templated language copied across patients is one of the fastest ways to turn a coverage question into a fraud referral, because it reads as a decision that was never actually made. Common denial patterns tied to product selection are catalogued in Skin Substitute Audits: Product Selection, Size, and Frequency Findings.
Measuring and Staging the Wound
Wound measurement is the evidentiary backbone of a medical-necessity file. Every encounter needs length, width, depth, and staging recorded in centimeters, using a consistent measurement method from visit to visit, so the record can show whether the wound is actually responding to treatment. Undermining, tunneling, and drainage characteristics belong in the same note, and each entry needs to be traceable to the clinician who performed and documented it, not a signature log gap an auditor can exploit. Where a claim also touches enforcement exposure rather than a routine denial, the government's legal theories are addressed in Skin Substitute FCA Enforcement: The Government's Theories, and the program-integrity contractor posture specific to wound care practices is covered in UPIC Audits of Wound Care Practices: What Triggers Them.
Why Early Legal Counsel Is Critical
It is critical that wound care providers promptly retain experienced healthcare defense counsel upon receiving a Medicare audit notice, an additional documentation request, or any other government inquiry into skin substitute billing. Early legal intervention can protect the provider's rights, ensure appropriate responses to the audit, avoid inadvertent admissions, preserve every available defense, and let counsel communicate with the Medicare Administrative Contractor on the provider's behalf. Delaying legal representation can significantly affect the outcome of a matter and expose the provider to unnecessary risk.
How Health Law Alliance Can Help
Health Law Alliance defends wound care providers against Medicare and Medicaid audits of skin substitute billing, from the initial records request through appeal. The firm evaluates the medical-necessity file the way a Medicare Administrative Contractor auditor will, before the auditor does. If your practice bills for skin substitute grafts, contact us for a free, confidential consultation.
